PTGX

Protagonist Therapeutics, Inc.NASDAQHealthcare

$103.78+0.11%ClosedMarket Cap: $6.62B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-19	JP Morgan	—	Overweight	—
2026-03-19	Citigroup	—	Buy	—
2026-03-19	Leerink Partners	—	Outperform	—
2026-03-19	Barclays	—	Overweight	—
2026-03-03	Goldman Sachs	—	Neutral	—
2026-02-26	Citizens	—	Market Outperform	—
2026-02-26	TD Cowen	—	Buy	—
2026-02-02	Jefferies	—	Buy	—
2026-01-30	HC Wainwright & Co.	—	Buy	—
2026-01-05	Truist Securities	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.68	$155.6M	7
Sun Dec 31	$1.56	$303.3M	6
Mon Dec 31	$2.57	$419.2M	4
Tue Dec 31	$4.65	$601.9M	2

PTGX | Protagonist Therapeutics, Inc. Analyst Ratings & Price Target - InvestLog